IRCCS Ca'Granda Maggiore Policlinic

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Melanoma

Running trials

• Active, not recruiting

  A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

  NCT06054555· Phase 3· Amgen· Source